Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Lung Cancer

Free Subscription Articles published in Cancer Lett Retrieve available abstracts of 109 articles: HTML format Text format

Single Articles

August 2019
1. KUANG Y, Wang Q
   Iron and Lung Cancer.
   Cancer Lett. 2019 Aug 19. pii: S0304-3835(19)30438.
   PubMed     Text format     Abstract available
   
   
   
2. FOURNEL L, Wu Z, Stadler N, Damotte D, et al
   Cisplatin increases PD-L1 expression and optimizes immune check-point blockade in non-small cell lung cancer.
   Cancer Lett. 2019 Aug 9. pii: S0304-3835(19)30428.
   PubMed     Text format     Abstract available
   
   
   June 2019
3. ZHANG YC, Zhou Q, Wu YL
   Clinical management of third-generation EGFR inhibitor-resistant patients with advanced non-small cell lung cancer: current status and future perspectives.
   Cancer Lett. 2019 Jun 12. pii: S0304-3835(19)30346.
   PubMed     Text format     Abstract available
   
   
   May 2019
4. LIU X, Pu W, He H, Fan X, et al
   Novel ROR1 Inhibitor ARI-1 Suppresses the Development of Non-Small Cell Lung Cancer.
   Cancer Lett. 2019 May 21. pii: S0304-3835(19)30311.
   PubMed     Text format     Abstract available
   
   
   March 2019
5. LI L, Wang Y, Jiao L, Lin C, et al
   Protective autophagy decreases osimertinib cytotoxicity through regulation of stem cell-like properties in lung cancer.
   Cancer Lett. 2019 Mar 22. pii: S0304-3835(19)30183.
   PubMed     Text format     Abstract available
   
   
   
6. EXPOSITO F, Villalba M, Redrado M, de Aberasturi AL, et al
   Targeting of TMPRSS4 sensitizes lung cancer cells to chemotherapy by impairing the proliferation machinery.
   Cancer Lett. 2019 Mar 21. pii: S0304-3835(19)30169.
   PubMed     Text format     Abstract available
   
   
   
7. SHIMOMURA I, Yokoi A, Kohama I, Kumazaki M, et al
   Drug library screen reveals benzimidazole derivatives as selective cytotoxic agents for KRAS-mutant lung cancer.
   Cancer Lett. 2019;451:11-22.
   PubMed     Text format     Abstract available
   
   
   
8. CASAL-MOURINO A, Valdes L, Barros-Dios JM, Ruano-Ravina A, et al
   Lung cancer survival among never smokers.
   Cancer Lett. 2019 Mar 6. pii: S0304-3835(19)30133.
   PubMed     Text format     Abstract available
   
   
   February 2019
9. LI L, Wang Y, Song G, Zhang X, et al
   HOX cluster-embedded antisense long non-coding RNAs in lung cancer.
   Cancer Lett. 2019 Feb 23. pii: S0304-3835(19)30114.
   PubMed     Text format     Abstract available
   
   
   
10. RUANO-RAVINA A, Rodriguez-Martinez A, Torres-Duran M, Barros-Dios JM, et al
    Reply: Residential radon and small cell lung cancer. A systematic review.
    Cancer Lett. 2019 Feb 4. pii: S0304-3835(19)30056.
    PubMed     Text format    
    
    
    
11. BEVELACQUA JJ, Dobrzynski L, Welsh J, Mortazavi SMJ, et al
    Commentary regarding "Residential radon and small cell lung cancer. A systematic review".
    Cancer Lett. 2019 Feb 4. pii: S0304-3835(19)30050.
    PubMed     Text format     Abstract available
    
    
    January 2019
12. LIU X, Min S, Wu N, Liu H, et al
    miR-193a-3p inhibition of the Slug activator PAK4 suppresses non-small cell lung cancer aggressiveness via the p53/Slug/L1CAM pathway.
    Cancer Lett. 2019;447:56-65.
    PubMed     Text format     Abstract available
    
    
    
13. NEGI H, Merugu SB, Mangukiya HB, Li Z, et al
    Anterior Gradient-2 Monoclonal Antibody Inhibits Lung Cancer Growth and Metastasis by Upregulating p53 Pathway and Without Exerting Any Toxicological Effects: A Preclinical Study.
    Cancer Lett. 2019 Jan 24. pii: S0304-3835(19)30045.
    PubMed     Text format     Abstract available
    
    
    
14. HUANG H, Wang Y, Li Q, Fei X, et al
    miR-140-3p functions as a tumor suppressor in squamous cell lung cancer by regulating BRD9.
    Cancer Lett. 2019 Jan 17. pii: S0304-3835(19)30019.
    PubMed     Text format     Abstract available
    
    
    
15. JUNG PY, Ryu H, Rhee KJ, Hwang S, et al
    Adipose tissue-derived mesenchymal stem cells cultured at high density express IFN-beta and TRAIL and suppress the growth of H460 human lung cancer cells.
    Cancer Lett. 2019;440-441:202-210.
    PubMed     Text format     Abstract available
    
    
    December 2018
16. PARK JH, Jung KH, Kim SJ, Yoon YC, et al
    HS-173 as a novel inducer of RIP3-dependent necroptosis in lung cancer.
    Cancer Lett. 2018 Dec 21. pii: S0304-3835(18)30721.
    PubMed     Text format     Abstract available
    
    
    
17. WU Z, Fournel L, Stadler N, Liu J, et al
    Modulation of lung cancer cell plasticity and heterogeneity with the restoration of cisplatin sensitivity by Neurotensin antibody.
    Cancer Lett. 2018 Dec 21. pii: S0304-3835(18)30722.
    PubMed     Text format     Abstract available
    
    
    November 2018
18. LUKIC A, Wahlund CJE, Gomez C, Brodin D, et al
    Exosomes and cells from lung cancer pleura exudates transform LTC4 to LTD4, promoting cell migration and survival via CysLT1.
    Cancer Lett. 2018 Nov 30. pii: S0304-3835(18)30699.
    PubMed     Text format     Abstract available
    
    
    
19. GU J, Mao W, Ren W, Xu F, et al
    Ubiquitin-protein Ligase E3C Maintains Non-small-cell Lung Cancer Stemness by Targeting AHNAK-p53 Complex.
    Cancer Lett. 2018 Nov 29. pii: S0304-3835(18)30695.
    PubMed     Text format     Abstract available
    
    
    
20. TREMBLE LF, O'Brien MA, Forde PF
    Electrochemotherapy with cisplatin increases survival and induces immunogenic responses in murine models of lung cancer and colorectal cancer.
    Cancer Lett. 2018 Nov 22. pii: S0304-3835(18)30680.
    PubMed     Text format     Abstract available
    
    
    
21. HUANG WT, Chong IW, Chen HL, Li CY, et al
    Pigment epithelium-derived factor inhibits lung cancer migration and invasion by upregulating exosomal thrombospondin 1.
    Cancer Lett. 2018 Nov 12. pii: S0304-3835(18)30646.
    PubMed     Text format     Abstract available
    
    
    October 2018
22. ZHANG P, Kang B, Xie G, Li S, et al
    Genomic sequencing and editing revealed the GRM8 signaling pathway as potential therapeutic targets of squamous cell lung cancer.
    Cancer Lett. 2018;442:53-67.
    PubMed     Text format     Abstract available
    
    
    
23. WANG Z, Fu S, Zhao J, Zhao W, et al
    Transbronchoscopic patient biopsy-derived xenografts as a preclinical model to explore chemorefractory-associated pathways and biomarkers for small-cell lung cancer.
    Cancer Lett. 2018 Oct 19. pii: S0304-3835(18)30628.
    PubMed     Text format     Abstract available
    
    
    September 2018
24. DI W, Yang B, Chen J, Xiong H, et al
    Upregulation of long non-coding RNA RAB1A-2 induces FGF1 expression worsening lung cancer prognosis.
    Cancer Lett. 2018 Sep 11. pii: S0304-3835(18)30571.
    PubMed     Text format     Abstract available
    
    
    August 2018
25. WANG Y, Wu L, Yao Y, Lu G, et al
    Polo-like kinase 1 inhibitor BI 6727 induces DNA damage and exerts strong antitumor activity in small cell lung cancer.
    Cancer Lett. 2018;436:1-9.
    PubMed     Text format     Abstract available
    
    
    July 2018
26. CHIANG CT, Demetriou AN, Ung N, Choudhury N, et al
    mTORC2 contributes to the metabolic reprogramming in EGFR tyrosine-kinase inhibitor resistant cells in non-small cell lung cancer.
    Cancer Lett. 2018 Jul 20. pii: S0304-3835(18)30483.
    PubMed     Text format     Abstract available
    
    
    
27. ZHANG DL, Qu LW, Ma L, Zhou YC, et al
    Genome-wide identification of transcription factors that are critical to non-small cell lung cancer.
    Cancer Lett. 2018 Jul 18. pii: S0304-3835(18)30478.
    PubMed     Text format     Abstract available
    
    
    
28. LEE YS, Jung YY, Park MH, Yeo IJ, et al
    Deficiency of parkin suppresses melanoma tumor development and metastasis through inhibition of MFN2 ubiquitination.
    Cancer Lett. 2018;433:156-164.
    PubMed     Text format     Abstract available
    
    
    June 2018
29. LU Z, Li Y, Che Y, Huang J, et al
    The TGFbeta-induced lncRNA TBILA promotes non-small cell lung cancer progression in vitro and in vivo via cis-regulating HGAL and activating S100A7/JAB1 signaling.
    Cancer Lett. 2018;432:156-168.
    PubMed     Text format     Abstract available
    
    
    May 2018
30. LU T, Li Z, Yang Y, Ji W, et al
    Corrigendum to "The Hippo/YAP1 pathway interacts with FGFR1 signaling to maintain stemness in lung cancer" [Canc. Lett. 423 (2018) 36-46].
    Cancer Lett. 2018 May 10. pii: S0304-3835(18)30275.
    PubMed     Text format    
    
    
    
31. HSU HY, Lin TY, Hu CH, Shu DTF, et al
    Fucoidan Upregulates TLR4/CHOP-Mediated Caspase-3 and PARP Activation to Enhance Cisplatin-Induced Cytotoxicity in Human Lung Cancer Cells.
    Cancer Lett. 2018 May 7. pii: S0304-3835(18)30325.
    PubMed     Text format     Abstract available
    
    
    April 2018
32. GUERARD M, Robin T, Perron P, Hatat AS, et al
    Nuclear translocation of IGF1R by intracellular amphiregulin contributes to the resistance of lung tumour cells to EGFR-TKI.
    Cancer Lett. 2018;420:146-155.
    PubMed     Text format     Abstract available
    
    
    
33. DU Q, Yan C, Wu SG, Zhang W, et al
    Development and validation of a novel diagnostic nomogram model based on tumor markers for assessing cancer risk of pulmonary lesions: A multicenter study in Chinese population.
    Cancer Lett. 2018;420:236-241.
    PubMed     Text format     Abstract available
    
    
    
34. YU F, Liu JB, Wu ZJ, Xie WT, et al
    Tumor suppressive microRNA-124a inhibits stemness and enhances gefitinib sensitivity of non-small cell lung cancer cells by targeting ubiquitin-specific protease 14.
    Cancer Lett. 2018 Apr 24. pii: S0304-3835(18)30289.
    PubMed     Text format     Abstract available
    
    
    
35. ZHAO X, Wu X, Qian M, Song Y, et al
    Knockdown of TGF-beta1 expression in human umbilical cord mesenchymal stem cells reverts their exosome-mediated EMT promoting effect on lung cancer cells.
    Cancer Lett. 2018 Apr 24. pii: S0304-3835(18)30293.
    PubMed     Text format     Abstract available
    
    
    
36. TAN W, Liao Y, Qiu Y, Liu H, et al
    miRNA 146a promotes chemotherapy resistance in lung cancer cells by targeting DNA damage inducible transcript 3 (CHOP).
    Cancer Lett. 2018 Apr 24. pii: S0304-3835(18)30295.
    PubMed     Text format     Abstract available
    
    
    
37. JING P, Zhao N, Ye M, Zhang Y, et al
    Protein arginine methyltransferase 5 promotes lung cancer metastasis via the epigenetic regulation of miR-99 family/FGFR3 signaling.
    Cancer Lett. 2018 Apr 18. pii: S0304-3835(18)30286.
    PubMed     Text format     Abstract available
    
    
    
38. YU X, Zhang Y, Ma X, Pertsemlidis A, et al
    miR-195 Potentiates the Efficacy of Microtubule-Targeting Agents in Non-Small Cell Lung Cancer.
    Cancer Lett. 2018 Apr 13. pii: S0304-3835(18)30268.
    PubMed     Text format     Abstract available
    
    
    
39. RODRIGUEZ-MARTINEZ A, Torres-Duran M, Barros-Dios JM, Ruano-Ravina A, et al
    Residential radon and small cell lung cancer. A systematic review.
    Cancer Lett. 2018 Apr 11. pii: S0304-3835(18)30264.
    PubMed     Text format     Abstract available
    
    
    
40. HU W, Bi ZY, Chen ZL, Liu C, et al
    Emerging landscape of circular RNAs in lung cancer.
    Cancer Lett. 2018 Apr 10. pii: S0304-3835(18)30267.
    PubMed     Text format     Abstract available
    
    
    
41. YAN C, Luo L, Urata Y, Goto S, et al
    Nicaraven reduces cancer metastasis to irradiated lungs by decreasing CCL8 and macrophage recruitment.
    Cancer Lett. 2018;418:204-210.
    PubMed     Text format     Abstract available
    
    
    March 2018
42. LI D, Wang H, Ding Y, Zhang Z, et al
    Targeting the NRF-2/RHOA/ROCK signaling pathway with a novel aziridonin, YD0514, to suppress breast cancer progression and lung metastasis.
    Cancer Lett. 2018;424:97-108.
    PubMed     Text format     Abstract available
    
    
    
43. LE HT, Nguyen HT, Min HY, Hyun SY, et al
    Corrigendum to "Panaxynol, a natural Hsp90 inhibitor, effectively targets both lung cancer stem and non-stem cells" [Canc. Lett. 412 (2018) 297-307].
    Cancer Lett. 2018 Mar 21. pii: S0304-3835(18)30220.
    PubMed     Text format    
    
    
    
44. CAO X, Zhou Y, Sun H, Xu M, et al
    EGFR-TKI-induced HSP70 degradation and BER suppression facilitate the occurrence of the EGFR T790M resistant mutation in lung cancer cells.
    Cancer Lett. 2018 Mar 7. pii: S0304-3835(18)30193.
    PubMed     Text format     Abstract available
    
    
    
45. ZHANG GN, Zhang YK, Wang YJ, Gupta P, et al
    Epidermal growth factor receptor (EGFR) inhibitor PD153035 reverses ABCG2-mediated multidrug resistance in non-small cell lung cancer: In vitro and in vivo.
    Cancer Lett. 2018 Mar 5. pii: S0304-3835(18)30181.
    PubMed     Text format     Abstract available
    
    
    February 2018
46. YANG YF, Lee YC, Lo S, Chung YN, et al
    A positive feedback loop of IL-17B-IL-17RB activates ERK/beta-catenin to promote lung cancer metastasis.
    Cancer Lett. 2018;422:44-55.
    PubMed     Text format     Abstract available
    
    
    
47. GOU W, Zhou X, Liu Z, Wang L, et al
    CD74-ROS1 G2032R mutation transcriptionally up-regulates Twist1 in non-small cell lung cancer cells leading to increased migration, invasion, and resistance to crizotinib.
    Cancer Lett. 2018 Feb 22. pii: S0304-3835(18)30171.
    PubMed     Text format     Abstract available
    
    
    
48. LU T, Li Z, Yang Y, Ji W, et al
    The Hippo/YAP1 pathway interacts with FGFR1 signaling to maintain stemness in lung cancer.
    Cancer Lett. 2018 Feb 13. pii: S0304-3835(18)30142.
    PubMed     Text format     Abstract available
    
    
    
49. SAIJO A, Goto H, Nakano M, Mitsuhashi A, et al
    Bone marrow-derived fibrocytes promote stem cell-like properties of lung cancer cells.
    Cancer Lett. 2018 Feb 12. pii: S0304-3835(18)30143.
    PubMed     Text format     Abstract available
    
    
    
50. TANG ZH, Lu JJ
    Osimertinib resistance in non-small cell lung cancer: Mechanisms and therapeutic strategies.
    Cancer Lett. 2018 Feb 6. pii: S0304-3835(18)30129.
    PubMed     Text format     Abstract available
    
    
    
51. ZHANG Y, Lin Q, Xu T, Deng W, et al
    Out of the darkness and into the light: New strategies for improving treatments for locally advanced non-small cell lung cancer.
    Cancer Lett. 2018 Feb 6. pii: S0304-3835(18)30128.
    PubMed     Text format     Abstract available
    
    
    
52. CHAI S, Qian Y, Tang J, Liang Z, et al
    Retraction notice to "Ca2+/Calmodulin-dependent protein kinase IIgamma, a critical mediator of the NF-kappaB network, is a novel therapeutic target in non-small cell lung cancer" [Cancer Lett. 344(1) (2014) 119-128].
    Cancer Lett. 2018;414:312.
    PubMed     Text format    
    
    
    
53. GRUNDEMANN C, Huber R
    Chemoprevention with isothiocyanates - From bench to bedside.
    Cancer Lett. 2018;414:26-33.
    PubMed     Text format     Abstract available
    
    
    January 2018
54. LI K, Sun D, Gou Q, Ke X, et al
    Long non-coding RNA linc00460 promotes epithelial-mesenchymal transition and cell migration in lung cancer cells.
    Cancer Lett. 2018 Jan 30. pii: S0304-3835(18)30093.
    PubMed     Text format     Abstract available
    
    
    
55. ZHANG Y, Zhang X, Ye M, Jing P, et al
    FBW7 loss promotes epithelial-to-mesenchymal transition in non-small cell lung cancer through the stabilization of Snail protein.
    Cancer Lett. 2018 Jan 17. pii: S0304-3835(18)30069.
    PubMed     Text format     Abstract available
    
    
    
56. LI C, Wan L, Liu Z, Xu G, et al
    Long non-coding RNA XIST promotes TGF-beta-induced epithelial-mesenchymal transition by regulating miR-367/141-ZEB2 axis in non-small-cell lung cancer.
    Cancer Lett. 2018 Jan 12. pii: S0304-3835(18)30058.
    PubMed     Text format     Abstract available
    
    
    
57. WU D, Zhao B, Qi X, Peng F, et al
    Nogo-B receptor promotes epithelial-mesenchymal transition in non-small cell lung cancer cells through the Ras/ERK/Snail1 pathway.
    Cancer Lett. 2018 Jan 10. pii: S0304-3835(18)30052.
    PubMed     Text format     Abstract available
    
    
    
58. WANG L, Syn NL, Subhash VV, Any Y, et al
    Pan-HDAC inhibition by panobinostat mediates chemosensitization to carboplatin in non-small cell lung cancer via attenuation of EGFR signaling.
    Cancer Lett. 2018 Jan 3. pii: S0304-3835(18)30003.
    PubMed     Text format     Abstract available
    
    
    
59. FU XT, Shi YH, Zhou J, Peng YF, et al
    MicroRNA-30a suppresses autophagy-mediated anoikis resistance and metastasis in hepatocellular carcinoma.
    Cancer Lett. 2018;412:108-117.
    PubMed     Text format     Abstract available
    
    
    December 2017
60. LEE JY, Talhi O, Jang D, Cerella C, et al
    Cytostatic hydroxycoumarin OT52 induces ER/Golgi stress and STAT3 inhibition triggering non-canonical cell death and synergy with BH3 mimetics in lung cancer.
    Cancer Lett. 2017;416:94-108.
    PubMed     Text format     Abstract available
    
    
    
61. MAO Q, Jiang F, Yin R, Wang J, et al
    Interplay between the lung microbiome and lung cancer.
    Cancer Lett. 2017;415:40-48.
    PubMed     Text format     Abstract available
    
    
    
62. TESSEMA M, Yingling CM, Picchi MA, Wu G, et al
    ANK1 Methylation regulates expression of MicroRNA-486-5p and discriminates lung tumors by histology and smoking status.
    Cancer Lett. 2017;410:191-200.
    PubMed     Text format     Abstract available
    
    
    
63. YOSHIKAWA Y, Takano O, Kato I, Takahashi Y, et al
    Ras inhibitors display an anti-metastatic effect by downregulation of lysyl oxidase through inhibition of the Ras-PI3K-Akt-HIF-1alpha pathway.
    Cancer Lett. 2017;410:82-91.
    PubMed     Text format     Abstract available
    
    
    November 2017
64. WANG J, Tian L, Khan MN, Zhang L, et al
    Ginsenoside Rg3 sensitizes hypoxic lung cancer cells to cisplatin via blocking of NF-kappaB mediated epithelial-mesenchymal transition and stemness.
    Cancer Lett. 2017 Nov 30. pii: S0304-3835(17)30762.
    PubMed     Text format     Abstract available
    
    
    
65. XUE X, Fei X, Hou W, Zhang Y, et al
    miR-342-3p suppresses cell proliferation and migration by targeting AGR2 in non-small cell lung cancer.
    Cancer Lett. 2017;412:170-178.
    PubMed     Text format     Abstract available
    
    
    
66. JING L, Song F, Liu Z, Li J, et al
    MLKL-PITPalpha signaling-mediated necroptosis contributes to cisplatin-triggered cell death in lung cancer A549 cells.
    Cancer Lett. 2017 Nov 2. pii: S0304-3835(17)30693.
    PubMed     Text format     Abstract available
    
    
    October 2017
67. LIU X, Chen B, You W, Xue S, et al
    The membrane bile acid receptor TGR5 drives cell growth and migration via activation of the JAK2/STAT3 signaling pathway in non-small cell lung cancer.
    Cancer Lett. 2017 Oct 23. pii: S0304-3835(17)30652.
    PubMed     Text format     Abstract available
    
    
    
68. LE HT, Nguyen HT, Min HY, Hyun SY, et al
    Panaxynol, a natural Hsp90 inhibitor, effectively targets both lung cancer stem and non-stem cells.
    Cancer Lett. 2017 Oct 20. pii: S0304-3835(17)30648.
    PubMed     Text format     Abstract available
    
    
    
69. LI X, Ma T, Zhang Q, Chen YG, et al
    Modified-FOLFIRINOX in metastatic pancreatic cancer: A prospective study in Chinese population.
    Cancer Lett. 2017;406:22-26.
    PubMed     Text format     Abstract available
    
    
    
70. TANG ZH, Cao WX, Guo X, Dai XY, et al
    Identification of a novel autophagic inhibitor cepharanthine to enhance the anti-cancer property of dacomitinib in non-small cell lung cancer.
    Cancer Lett. 2017 Oct 9. pii: S0304-3835(17)30624.
    PubMed     Text format     Abstract available
    
    
    
71. TORRES-DURAN M, Ruano-Ravina A, Kelsey KT, Parente-Lamelas I, et al
    Environmental tobacco smoke exposure and EGFR and ALK alterations in never smokers' lung cancer. Results from the LCRINS study.
    Cancer Lett. 2017 Oct 5. pii: S0304-3835(17)30603.
    PubMed     Text format     Abstract available
    
    
    
72. YANG H, Lee MH, Park I, Jeon H, et al
    HSP90 inhibitor (NVP-AUY922) enhances the anti-cancer effect of BCL-2 inhibitor (ABT-737) in small cell lung cancer expressing BCL-2.
    Cancer Lett. 2017;411:19-26.
    PubMed     Text format     Abstract available
    
    
    
73. BETTI M, Casalone E, Ferrante D, Aspesi A, et al
    Germline mutations in DNA repair genes predispose asbestos-exposed patients to malignant pleural mesothelioma.
    Cancer Lett. 2017;405:38-45.
    PubMed     Text format     Abstract available
    
    
    September 2017
74. HUANG GX, Wang Y, Su J, Zhou P, et al
    Up-regulation of Rho-associated kinase 1/2 by glucocorticoids promotes migration, invasion and metastasis of melanoma.
    Cancer Lett. 2017 Sep 15. pii: S0304-3835(17)30552.
    PubMed     Text format     Abstract available
    
    
    
75. KIM SJ, Jung KH, Son MK, Park JH, et al
    Tumor vessel normalization by the PI3K inhibitor HS-173 enhances drug delivery.
    Cancer Lett. 2017;403:339-353.
    PubMed     Text format     Abstract available
    
    
    
76. CHAN KK, Leung CO, Wong CC, Ho DW, et al
    Secretory Stanniocalcin 1 promotes metastasis of hepatocellular carcinoma through activation of JNK signaling pathway.
    Cancer Lett. 2017;403:330-338.
    PubMed     Text format     Abstract available
    
    
    
77. CAO L, Qi L, Zhang L, Song W, et al
    Human nonsense-mediated RNA decay regulates EMT by targeting the TGF-ss signaling pathway in lung adenocarcinoma.
    Cancer Lett. 2017;403:246-259.
    PubMed     Text format     Abstract available
    
    
    
78. LIU CH, Lan CT, Chou JF, Tseng TJ, et al
    CHSY1 promotes aggressive phenotypes of hepatocellular carcinoma cells via activation of the hedgehog signaling pathway.
    Cancer Lett. 2017;403:280-288.
    PubMed     Text format     Abstract available
    
    
    
79. LIANG Z, Cheng Y, Chen Y, Hu Y, et al
    EGFR T790M ctDNA testing platforms and their role as companion diagnostics: Correlation with clinical outcomes to EGFR-TKIs.
    Cancer Lett. 2017;403:186-194.
    PubMed     Text format     Abstract available
    
    
    
80. WANG C, Zhou X, Li W, Li M, et al
    Macrophage migration inhibitory factor promotes osteosarcoma growth and lung metastasis through activating the RAS/MAPK pathway.
    Cancer Lett. 2017;403:271-279.
    PubMed     Text format     Abstract available
    
    
    
81. ZHOU J, Zhang S, Chen X, Zheng X, et al
    Palbociclib, a selective CDK4/6 inhibitor, enhances the effect of selumetinib in RAS-driven non-small cell lung cancer.
    Cancer Lett. 2017 Sep 1. pii: S0304-3835(17)30518.
    PubMed     Text format     Abstract available
    
    
    August 2017
82. BAI Z, Gao M, Zhang H, Guan Q, et al
    BZML, a novel colchicine binding site inhibitor, overcomes multidrug resistance in A549/Taxol cells by inhibiting P-gp function and inducing mitotic catastrophe.
    Cancer Lett. 2017;402:81-92.
    PubMed     Text format     Abstract available
    
    
    
83. WANG ZQ, He CY, Hu L, Shi HP, et al
    Long noncoding RNA UCA1 promotes tumour metastasis by inducing GRK2 degradation in gastric cancer.
    Cancer Lett. 2017 Aug 23. pii: S0304-3835(17)30490.
    PubMed     Text format     Abstract available
    
    
    
84. ZHOU L, Lv T, Zhang Q, Zhu Q, et al
    The biology, function and clinical implications of exosomes in lung cancer.
    Cancer Lett. 2017 Aug 12. pii: S0304-3835(17)30480.
    PubMed     Text format     Abstract available
    
    
    
85. PARK KS, Yang H, Choi J, Seo S, et al
    The HSP90 inhibitor, NVP-AUY922, attenuates intrinsic PI3K inhibitor resistance in KRAS-mutant non-small cell lung cancer.
    Cancer Lett. 2017 Aug 7. pii: S0304-3835(17)30464.
    PubMed     Text format     Abstract available
    
    
    
86. PISANU ME, Noto A, De Vitis C, Morrone S, et al
    Blockade of Stearoyl-CoA-Desaturase 1 activity reverts resistance to Cisplatin in lung cancer stem cells.
    Cancer Lett. 2017 Aug 7. pii: S0304-3835(17)30463.
    PubMed     Text format     Abstract available
    
    
    
87. LI J, Tian H, Pan J, Jiang N, et al
    Pecanex functions as a competitive endogenous RNA of S-phase kinase associated protein 2 in lung cancer.
    Cancer Lett. 2017 Aug 5. pii: S0304-3835(17)30466.
    PubMed     Text format     Abstract available
    
    
    
88. YANG D, Cao X, Wang F, Jiang H, et al
    LFG-500, a novel synthetic flavonoid, suppresses epithelial-mesenchymal transition in human lung adenocarcinoma cells by inhibiting NLRP3 in inflammatory microenvironment.
    Cancer Lett. 2017;400:137-148.
    PubMed     Text format     Abstract available
    
    
    
89. WU J, He Z, Yang XM, Li KL, et al
    RCCD1 depletion attenuates TGF-beta-induced EMT and cell migration by stabilizing cytoskeletal microtubules in NSCLC cells.
    Cancer Lett. 2017;400:18-29.
    PubMed     Text format     Abstract available
    
    
    July 2017
90. TONG CWS, Wu WKK, Loong HHF, Cho WCS, et al
    Drug combination approach to overcome resistance to EGFR tyrosine kinase inhibitors in lung cancer.
    Cancer Lett. 2017 Jul 31. pii: S0304-3835(17)30459.
    PubMed     Text format     Abstract available
    
    
    
91. STAPELFELD C, Neumann KT, Maser E
    Different inhibitory potential of sex hormones on NNK detoxification in vitro: a possible explanation for gender-specific lung cancer risk.
    Cancer Lett. 2017 Jul 22. pii: S0304-3835(17)30451.
    PubMed     Text format     Abstract available
    
    
    
92. MENG X, Liu Y, Zhang J, Teng F, et al
    PD-1/PD-L1 checkpoint blockades in non-small cell lung cancer: New development and challenges.
    Cancer Lett. 2017 Jul 6. pii: S0304-3835(17)30415.
    PubMed     Text format     Abstract available
    
    
    
93. GORZALCZANY Y, Akiva E, Klein O, Merimsky O, et al
    Mast cells are directly activated by contact with cancer cells by a mechanism involving autocrine formation of adenosine and autocrine/paracrine signaling of the adenosine A3 receptor.
    Cancer Lett. 2017;397:23-32.
    PubMed     Text format     Abstract available
    
    
    June 2017
94. BROCK M, Mei Y
    Protein functional effector sncRNAs (pfeRNAs) in lung cancer.
    Cancer Lett. 2017 Jun 19. pii: S0304-3835(17)30394.
    PubMed     Text format     Abstract available
    
    
    
95. DENG M, Zeng C, Lu X, He X, et al
    miR-218 suppresses gastric cancer cell cycle progression through the CDK6/Cyclin D1/E2F1 axis in a feedback loop.
    Cancer Lett. 2017 Jun 17. pii: S0304-3835(17)30387.
    PubMed     Text format     Abstract available
    
    
    
96. CHANG TH, Tsai MF, Gow CH, Wu SG, et al
    Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C.
    Cancer Lett. 2017;402:190-202.
    PubMed     Text format     Abstract available
    
    
    
97. CHANG YC, Chan YC, Chang WM, Lin YF, et al
    Feedback regulation of ALDOA activates the HIF-1alpha/MMP9 axis to promote lung cancer progression.
    Cancer Lett. 2017;403:28-36.
    PubMed     Text format     Abstract available
    
    
    
98. KWON OS, Hong SK, Kwon SJ, Go YH, et al
    BCL2 induced by LAMTOR3/MAPK is a druggable target of chemoradioresistance in mesenchymal lung cancer.
    Cancer Lett. 2017 Jun 10. pii: S0304-3835(17)30355.
    PubMed     Text format     Abstract available
    
    
    
99. DONG X, Liao W, Zhang L, Tu X, et al
    RSPO2 suppresses colorectal cancer metastasis by counteracting the Wnt5a/Fzd7-driven noncanonical Wnt pathway.
    Cancer Lett. 2017 Jun 6. pii: S0304-3835(17)30370.
    PubMed     Text format     Abstract available
    
    
    
100. NERI S, Miyashita T, Hashimoto H, Suda Y, et al
     Fibroblast-led cancer cell invasion is activated by epithelial-mesenchymal transition through platelet-derived growth factor BB secretion of lung adenocarcinoma.
     Cancer Lett. 2017;395:20-30.
     PubMed     Text format     Abstract available
     
     
     May 2017
101. SILVA PM, Ribeiro N, Lima RT, Andrade C, et al
     Suppression of spindly delays mitotic exit and exacerbates cell death response of cancer cells treated with low doses of paclitaxel.
     Cancer Lett. 2017;394:33-42.
     PubMed     Text format     Abstract available
     
     
     
102. CHEN S, Dong Z, Yang P, Wang X, et al
     Hepatitis B virus X protein stimulates high mobility group box 1 secretion and enhances hepatocellular carcinoma metastasis.
     Cancer Lett. 2017;394:22-32.
     PubMed     Text format     Abstract available
     
     
     
103. CASTANON E, Soltermann A, Lopez I, Roman M, et al
     The inhibitor of differentiation-1 (Id1) enables lung cancer liver colonization through activation of an EMT program in tumor cells and establishment of the pre-metastatic niche.
     Cancer Lett. 2017 May 24. pii: S0304-3835(17)30342.
     PubMed     Text format     Abstract available
     
     
     
104. ZHANG J, Kong L, Jiao Q, Li M, et al
     Stereotactic ablative radiotherapy in treatment of early-stage non-small cell lung cancer: Unsolved questions and frontiers ahead.
     Cancer Lett. 2017 May 16. pii: S0304-3835(17)30311.
     PubMed     Text format     Abstract available
     
     
     April 2017
105. WANG Y, Zhou Y, Tao F, Chai S, et al
     N-myc downstream regulated gene 1(NDRG1) promotes the stem-like properties of lung cancer cells through stabilized c-Myc.
     Cancer Lett. 2017 Apr 26. pii: S0304-3835(17)30292.
     PubMed     Text format     Abstract available
     
     
     February 2017
106. SHEN CJ, Chan SH, Lee CT, Huang WC, et al
     Oleic acid-induced ANGPTL4 enhances head and neck squamous cell carcinoma anoikis resistance and metastasis via up-regulation of fibronectin.
     Cancer Lett. 2017;386:110-122.
     PubMed     Text format     Abstract available
     
     
     November 2016
107. KIM JY, Lee N, Kim YJ, Cho Y, et al
     Disulfiram induces anoikis and suppresses lung colonization in triple-negative breast cancer via calpain activation.
     Cancer Lett. 2016 Nov 25. pii: S0304-3835(16)30710.
     PubMed     Text format     Abstract available
     
     
     
108. ZYSK A, DeNichilo MO, Panagopoulos V, Zinonos I, et al
     Adoptive transfer of ex vivo expanded Vgamma9Vdelta2 T cells in combination with zoledronic acid inhibits cancer growth and limits osteolysis in a murine model of osteolytic breast cancer.
     Cancer Lett. 2016 Nov 16. pii: S0304-3835(16)30699.
     PubMed     Text format     Abstract available
     
     
     July 2016
109. KONG J, Sun W, Li C, Wan L, et al
     Long non-coding RNA LINC01133 inhibits epithelial-mesenchymal transition and metastasis in colorectal cancer by interacting with SRSF6.
     Cancer Lett. 2016;380:476-484.
     PubMed     Text format     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: